Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.

Fulton LM, Carlson MJ, Coghill JM, Ott LE, West ML, Panoskaltsis-Mortari A, Littman DR, Blazar BR, Serody JS.

J Immunol. 2012 Aug 15;189(4):1765-72. doi: 10.4049/jimmunol.1200858. Epub 2012 Jul 9.

PMID:
22778391
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation.

Joo YD, Lee WS, Won HJ, Lee SM, Kim HR, Park JK, Park SG, Choi IW, Choi I, Seo SK.

Cytokine. 2012 Oct;60(1):277-83. doi: 10.1016/j.cyto.2012.06.289. Epub 2012 Jul 21.

PMID:
22819244
[PubMed - indexed for MEDLINE]
3.

T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.

Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C, Yu XZ.

Biol Blood Marrow Transplant. 2010 Feb;16(2):170-8. doi: 10.1016/j.bbmt.2009.09.023. Epub 2009 Oct 2.

PMID:
19804837
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.

Park MJ, Moon SJ, Lee SH, Yang EJ, Min JK, Cho SG, Yang CW, Park SH, Kim HY, Cho ML.

PLoS One. 2013 Jun 20;8(6):e67171. doi: 10.1371/journal.pone.0067171. Print 2013.

PMID:
23840617
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Yu Y, Wang D, Liu C, Kaosaard K, Semple K, Anasetti C, Yu XZ.

Blood. 2011 Nov 3;118(18):5011-20. doi: 10.1182/blood-2011-03-340315. Epub 2011 Aug 19.

PMID:
21856864
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M.

Blood. 1997 Dec 1;90(11):4651-60.

PMID:
9373279
[PubMed - indexed for MEDLINE]
Free Article
7.

Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, Johnston H, Young J, Todorov I, Umetsu DT, Chen L, Iwakura Y, Kandeel F, Forman S, Zeng D.

Blood. 2009 Oct 1;114(14):3101-12. doi: 10.1182/blood-2009-05-219402. Epub 2009 Jul 14.

PMID:
19602708
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.

Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C.

J Immunol. 2006 Jun 15;176(12):7394-401.

PMID:
16751384
[PubMed - indexed for MEDLINE]
Free Article
9.

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D.

Blood. 2008 Sep 1;112(5):2101-10. doi: 10.1182/blood-2007-12-126987. Epub 2008 Jul 2.

PMID:
18596226
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.

Min CK, Maeda Y, Lowler K, Liu C, Clouthier S, Lofthus D, Weisiger E, Ferrara JL, Reddy P.

Blood. 2004 Nov 15;104(10):3393-9. Epub 2004 Jul 27.

PMID:
15280194
[PubMed - indexed for MEDLINE]
Free Article
11.

Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.

Johnson BD, Becker EE, Truitt RL.

Biol Blood Marrow Transplant. 1999;5(3):123-32.

PMID:
10392958
[PubMed - indexed for MEDLINE]
12.

Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.

Zeis M, Uharek L, Hartung G, Glass B, Steinmann J, Schmitz N.

Hematol J. 2001;2(2):136-44.

PMID:
11424006
[PubMed - indexed for MEDLINE]
13.

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA.

Blood. 2003 May 1;101(9):3741-8. Epub 2003 Jan 9.

PMID:
12521997
[PubMed - indexed for MEDLINE]
Free Article
14.

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.

Yang YG, Qi J, Wang MG, Sykes M.

Blood. 2002 Jun 1;99(11):4207-15.

PMID:
12010827
[PubMed - indexed for MEDLINE]
Free Article
15.

Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.

Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ.

J Immunol. 2013 Feb 1;190(3):1351-9. doi: 10.4049/jimmunol.1200391. Epub 2012 Dec 28.

PMID:
23275602
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.

Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ.

J Immunol. 2012 Aug 15;189(4):2033-42. doi: 10.4049/jimmunol.1102853. Epub 2012 Jul 9.

PMID:
22778394
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.

Zhang Y, Hexner E, Frank D, Emerson SG.

J Immunol. 2007 Sep 1;179(5):3305-14.

PMID:
17709547
[PubMed - indexed for MEDLINE]
Free Article
18.

CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.

Liu K, Anthony BA, Yearsly MM, Hamadani M, Gaughan A, Wang JJ, Devine SM, Hadley GA.

PLoS One. 2011;6(7):e21968. doi: 10.1371/journal.pone.0021968. Epub 2011 Jul 14.

PMID:
21779359
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.

Mutis T, Aarts-Riemens T, Verdonck LF.

Haematologica. 2005 Oct;90(10):1389-95.

PMID:
16219576
[PubMed - indexed for MEDLINE]
Free Article
20.

Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.

Zhao F, Zhang Y, Wang H, Jin M, He S, Shi Y, Guo Y, Zhang Y.

Blood. 2011 Feb 3;117(5):1723-33. doi: 10.1182/blood-2010-04-281659. Epub 2010 Nov 30.

PMID:
21119110
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk